Stocks and Investing Stocks and Investing
Thu, April 17, 2014
Wed, April 16, 2014
Tue, April 15, 2014
Mon, April 14, 2014
Fri, April 11, 2014
Thu, April 10, 2014
Wed, April 9, 2014
Tue, April 8, 2014
Mon, April 7, 2014
Fri, April 4, 2014
Thu, April 3, 2014
Wed, April 2, 2014
Tue, April 1, 2014
Mon, March 31, 2014
Fri, March 28, 2014
Thu, March 27, 2014
Wed, March 26, 2014
Tue, March 25, 2014
Mon, March 24, 2014
Fri, March 21, 2014
Thu, March 20, 2014
Wed, March 19, 2014
Tue, March 18, 2014
Mon, March 17, 2014
Fri, March 14, 2014

Chris Schott Upgraded (TEVA) to Hold and Held Target at $49 on, Mar 14th, 2014


Published on 2024-10-25 04:26:46 - WOPRAI, Chris Schott
  Print publication without navigation


Chris Schott of JP Morgan, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Held Target at $49 on, Mar 14th, 2014.

Chris has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with Chris's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Randall Stanicky of "RBC Capital" Initiated at Hold and Held Target at $39 on, Monday, January 6th, 2014


These are the ratings of the 2 analyists that currently disagree with Chris


  • Ami Fadia of "Leerink Swann" Upgraded from Hold to Buy on, Thursday, March 6th, 2014
  • Liav Abraham of "Citigroup" Maintained at Strong Buy with Increased Target to $56 on, Monday, March 3rd, 2014